Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NRROS | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-07 |
mRNA | HNRNPA0 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | SMAD9 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-08 |
mRNA | FBRSL1 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-10 |
mRNA | ZNF184 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-09 |
mRNA | MEX3A | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-08 |
mRNA | ILF3 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-09 |
mRNA | DOT1L | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-07 |
mRNA | SOX11 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-07 |
mRNA | HCFC1 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-09 |